STAGE IIA PROSTATE CANCER
Clinical trials for STAGE IIA PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation approach targets returning prostate cancer with fewer side effects
Disease control OngoingThis early-phase study tested a high-precision radiation technique called stereotactic body radiation therapy (SBRT) in 26 men whose prostate cancer had returned after surgery. The goal was to find the safest and most effective dose by monitoring side effects. The approach aims t…
Matched conditions: STAGE IIA PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New radiation combo aims to safely shrink prostate tumors in fewer sessions
Disease control OngoingThis early-phase trial tests the safety of combining two types of radiation for men with intermediate-risk prostate cancer. Participants first receive a short internal radiation treatment (brachytherapy), followed by three weeks of highly targeted external radiation (SBRT). The g…
Matched conditions: STAGE IIA PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New radiation approach targets prostate cancer from the inside
Disease control OngoingThis study looks at a type of radiation therapy called high-dose-rate brachytherapy for men with prostate cancer that hasn't spread. Doctors place tiny radioactive sources directly into the prostate to deliver a strong dose of radiation to the tumor while sparing nearby healthy t…
Matched conditions: STAGE IIA PROSTATE CANCER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC